Surveyor Capital's book
19 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Kailera Therapeutics (NAS: KLRA) | — | $1.5B | — | — | |
| 35Pharma | — | $950.0M | — | — | |
| Soley Therapeutics | — | $700.0M | — | — | |
| Merlyn Mind | — | $668.0M | — | — | |
| VeraDermics (NYS: MANE) | Drug Discovery | $596.3M | — | — | |
| Avenzo Therapeutics | — | $590.0M | — | — | |
| Solve Therapeutics | — | $439.0M | — | — | |
| Marea | — | $272.0M | — | — | |
| Neuron23 | — | $271.5M | — | — | |
| Vanqua Bio | — | $270.0M | — | — | |
| + 9 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 19 recorded positions
- ·Watchlist + alerts for Surveyor Capital's activity
Create free account
No card required